Sign in

CIK 0001750284

  • Non-accelerated filer
  • Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300409740
Phone
+1 415-651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-11-19 BVF PARTNERS L P/IL Director Conversion · Series C Convertible Preferred Stock −760,155 0
2020-11-19 BVF PARTNERS L P/IL Director Conversion · Series C Convertible Preferred Stock −522,403 0
2020-11-19 BVF PARTNERS L P/IL Director Conversion · Series C Convertible Preferred Stock −73,399 0
2020-11-18 Harmon Cyrus Chief Technology Officer Grant or award · Stock Option (Right to Buy) +1,076 1,076
2020-11-18 BVF PARTNERS L P/IL Director Grant or award · Stock Option (Right to buy) +21,520 21,520
2020-11-18 BVF PARTNERS L P/IL Director Grant or award · Stock Option (Right to buy) +21,520 21,520
2020-11-18 BVF PARTNERS L P/IL Director Grant or award · Stock Option (Right to buy) +21,520 21,520
2020-11-18 Graham G. Walmsley Director Grant or award · Stock Option (Right to Buy) +21,520 21,520
2020-11-18 Graham G. Walmsley Director Grant or award · Stock Option (Right to Buy) +21,520 21,520
2020-11-18 Graham G. Walmsley Director Grant or award · Stock Option (Right to Buy) +21,520 21,520
2020-11-18 RAPPAPORT ANDREW Director Grant or award · Stock Option (Right to Buy) +21,520 21,520
2020-11-18 Myles David C. Chief Development Officer Grant or award · Stock Option (Right to Buy) +179,340 179,340
2020-11-18 Moriarty John B EVP, Ch. Legal Officer & Sec. Grant or award · Stock Option (Right to Buy) +161,406 161,406
2020-11-18 MCCORMICK FRANK Director Grant or award · Stock Option (Right to Buy) +21,520 21,520
2020-11-18 Kushner Peter J. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +179,340 179,340
2020-11-18 Kovacs Shane William Charles Ch. Operating & Financial Off. Grant or award · Stock Option (Right to Buy) +107,604 107,604
2020-11-18 Hrustanovic Gorjan Director Grant or award · Stock Option (Right to Buy) +21,520 21,520
2020-11-18 Hrustanovic Gorjan Director Grant or award · Stock Option (Right to Buy) +21,520 21,520
2020-11-18 Hrustanovic Gorjan Director Grant or award · Stock Option (Right to Buy) +21,520 21,520
2020-11-18 Horning Sandra Director Grant or award · Stock Option (Right to Buy) +86,083 86,083

Page 22 of 24 · 465 trades